Department of Dermatology Institute of Pathology, Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel.
J Eur Acad Dermatol Venereol. 2012 Sep;26(9):1158-62. doi: 10.1111/j.1468-3083.2011.04189.x. Epub 2011 Jul 26.
Lentigines are a common pigmentary disorder in adults and in patients treated by psoralen and ultraviolet A (PUVA) radiation. Their appearance following treatment with narrow-band ultraviolet B (NB-UVB) radiation has been reported in only two patients.
To describe the clinical and histological features of NB-UVB-induced lentigines their relation to dosimetry and the course of the eruption in patients with mycosis fungoides (MF).
The files of all patients with MF treated in our department in 2003-2010 were searched to identify those in whom lentigines appeared following monotherapy with NB-UVB radiation.
Of the 73 patients with early stage MF identified, 10 met the study criteria. Lentigines were detected in skin previously involved by MF in seven patients, and in both involved and uninvolved skin in three patients. They appeared during therapy in three patients, after a mean of 56 exposures (range 50-61), and several months (mean 7.8) following completion of treatment in seven patients, after a mean of 69 exposures (range 32-157). Histopathological study of lesions from five patients revealed basal hyperpigmentation relative to adjacent normal-looking skin. Two lesions had a slight increased number of normal-looking melanocytes on immunohistochemical staining with melanoma cocktail. One lesion had elongated rete ridges. The lesions persisted throughout follow-up (mean 26.7 months) in 8 patients.
Patients with MF treated with NB-UVB may acquire lentigines. As opposed to PUVA-induced lentigines which are a known common side-effect of long-term treatment, NB-UVB-induced lentigines are uncommon but appear earlier, even after a few months of treatment.
色素沉着过度是成人和光化学疗法(PUVA)治疗患者中常见的色素障碍。窄谱中波紫外线(NB-UVB)治疗后出现这种情况仅在两名患者中报告过。
描述 NB-UVB 诱导的色素沉着过度的临床和组织学特征,及其与蕈样肉芽肿(MF)患者放射剂量和发疹过程的关系。
检索了 2003 年至 2010 年期间在我科接受治疗的所有 MF 患者的档案,以确定那些在 NB-UVB 单一疗法后出现色素沉着过度的患者。
在确定的 73 例早期 MF 患者中,有 10 例符合研究标准。在 7 例患者中,色素沉着过度出现在先前受累的 MF 皮肤部位,而在 3 例患者中,色素沉着过度出现在受累和未受累的皮肤部位。在 3 例患者中,治疗期间出现了色素沉着过度,平均接受了 56 次照射(范围 50-61 次),而在另外 7 例患者中,治疗结束后几个月(平均 7.8 个月)出现了色素沉着过度,平均接受了 69 次照射(范围 32-157 次)。对 5 例患者的病变进行组织病理学研究发现,与相邻外观正常的皮肤相比,基底有色素过度沉着。在黑色素瘤鸡尾酒免疫组化染色中,有 2 个病变的外观正常黑素细胞略有增加。一个病变有伸长的网嵴。在 8 例患者中,病变在整个随访期间(平均 26.7 个月)持续存在。
接受 NB-UVB 治疗的 MF 患者可能会获得色素沉着过度。与长期治疗已知的常见副作用 PUVA 诱导的色素沉着过度不同,NB-UVB 诱导的色素沉着过度并不常见,但出现较早,甚至在治疗几个月后就会出现。